Supernus Pharmaceuticals, Inc. (SUPN) compared with its closest peers (AMPH, EBS, CORT, RARE, COLL). Peer set by Pharmaceutical Products; 10 comparable drugmakers. First-party data.
Amphastar Pharmaceuticals, Emergent BioSolutions, Corcept Therapeutics, Ultragenyx Pharmaceutical, Collegium Pharmaceutical, Axsome Therapeutics, Arrowhead Pharmaceuticals, TG Therapeutics, OPKO Health and Insmed share Supernus Pharmaceuticals's sub-industry, pharmaceutical makers.
| Company | Market Cap | P/E |
|---|---|---|
| Amphastar Pharmaceuticals, Inc. (AMPH) | $952.41M | 15.7 |
| Emergent BioSolutions Inc. (EBS) | $262.37M | 2.3 |
| Corcept Therapeutics Incorporated (CORT) | $13.22B | 42.5 |
| Ultragenyx Pharmaceutical Inc. (RARE) | $2.59B | -3.9 |
| Collegium Pharmaceutical, Inc. (COLL) | $882.75M | 19.4 |
| Axsome Therapeutics, Inc. (AXSM) | $10.88B | -49.7 |
| Arrowhead Pharmaceuticals, Inc. (ARWR) | $12.31B | -3453.0 |
| TG Therapeutics, Inc. (TGTX) | $8.31B | 18.7 |
| OPKO Health, Inc. (OPK) | $1.10B | -4.2 |
| Insmed Incorporated (INSM) | $27.47B | -27.1 |
| Sector P/E (Healthcare) | 21.7 |
| Industry P/E (Pharmaceutical Products) | 17.2 |
SUPN overview · SUPN earnings · SUPN financials · SUPN KPIs · SUPN documents · SUPN ownership
Data sourced from U.S. SEC EDGAR filings and market data. Not personalized investment advice.